Novartis AG | NOVN Logo | Annual Report & Investor Relations Data

Novartis AG | NOVN - Annual Report & Investor Relations Data

Novartis AG | NOVN
Annual Report & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Ticker

NOVN

Sector

Health Care

Industry

Pharmaceuticals

Country

Switzerland

Year Founded

1859

Novartis AG (NOVN)

About Novartis AG

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.

Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.

Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

Employees

110,000

Market Presence

Worldwide

Headquarters

LICHTSTR. 35
4056, BASEL
Switzerland

Company Video

Video thumbnail
Click to load video from YouTube

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Novartis AG (NOVN)
Filings & Annual Reports

Filters

View all types
Filing Information Actions

Insider Trading Activity

Person (Position) Type Volume Price Date
None (Non-Executive member)
Buy CHF 160,000.00 CHF 160,000.00 07.03.25
None (Executive member)
Sell CHF 312,203.18 CHF 97.56 11.02.25
None (Executive member)
Sell CHF 2,500,278.74 CHF 97.48 07.02.25
None (Executive member)
Sell CHF 1,365,687.19 CHF 97.15 05.02.25
None (Executive member)
Sell CHF 1,840,201.00 CHF 96.70 04.02.25
None (Executive member)
Buy CHF 699,424.74 CHF 90.26 30.01.25
None (Executive member)
Buy CHF 698,883.18 CHF 90.26 30.01.25
None (Executive member)
Sell CHF 1.00 CHF 0.00 19.12.24
None (Executive member)
Sell CHF 167,294.98 CHF 92.58 29.11.24
None (Executive member)
Sell CHF 1,005,347.74 CHF 92.23 27.11.24

Novartis AG (NOVN)
Stock & Investor Information

ISINs

Showing 5 of 11
CH0012005267
CH0038459415
CH0270190983
CH0270190991
CH0270191007

LEI

5493007HIVTX6SY6XD66

Stock Exchange Listings

SIX Swiss Exchange

Stock Index

SMI STOXX Europe 600

Industry Classification

Novartis AG (NOVN)
Related Companies & Peer Group

ABIVAX Logo

ABIVAX

ABVX

Sector

Health Care

Country

France

ISIN

FR0012333284

Founded

Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …

Addex Therapeutics Ltd Logo

Addex Therapeutics Ltd

ADXN

Sector

Health Care

Country

Switzerland

ISIN

CH0029850754

Founded

2002

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …

AegirBio AB Logo

AegirBio AB

AEGIR

Sector

Health Care

Country

Sweden

ISIN

SE0014401121

Founded

2019

AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …

AGRONOMICS LIMITED Logo

AGRONOMICS LIMITED

ANIC

Sector

Health Care

Country

Isle of Man

ISIN

Founded

Allergy Therapeutics PLC: Global immunology leader, researching, developing, and manufacturing convenient allergy treatments.Ê Our mission: Transforming lives through innovative immunotherapy.

AIREA PLC Logo

AIREA PLC

AIEA

Sector

Health Care

Country

United Kingdom

ISIN

Founded

Alliance Pharma PLC improves lives through clinically valuable healthcare products. We market consumer & prescription medicines, leveraging an asset-light model …

Alkaloid AD Logo

Alkaloid AD

ALK

Sector

Health Care

Country

North Macedonia

ISIN

MKALKA101011

Founded

1936

Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …